United States · Bill · HR
H.R. 1476 (119th)
PLASMA Act
Introduced
21 February 2025
Last action
21 February 2025 · Introduced
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsors
Rep. Hudson, Richard [R-NC-8], Rep. Davis, Donald G. [D-NC-1], Rep. Murphy, Gregory F. [R-NC-3], Rep. Peters, Scott H. [D-CA-50], Rep. Rouzer, David [R-NC-7], Rep. Knott, Brad [R-NC-13]
Subjects
Healthcare
Source updated
5 December 2025
Summary
Preserving Life-saving Access to Specialty Medicines in America Act or the PLASMA Act This bill phases-in certain price adjustments for plasma-derived products under the Medicare prescription drug benefit's Manufacturer Discount Program. Current law requires manufacturers of covered drugs under the Medicare prescription drug benefit to provide a 10% discount for covered drugs during the initial coverage phase (i.e., before a beneficiary reaches the out-of-pocket spending threshold) and a 20% discount during the catastrophic coverage phase (i.e., after a beneficiary reaches the out-of-pocket spending threshold). The bill phases-in discounts for plasma-derived products over several years, starting with a 1% discount in 2026 for both the initial and catastrophic coverage phases, and ending with a 10% discount beginning in 2030 for the initial coverage phase and a 20% discount beginning in 2032 for the catastrophic coverage phase.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
21 February 2025
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
21 February 2025
Introduced
Introduced in House
Source: IntroReferral
21 February 2025
Introduced
Introduced in House
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
2 official files
Introduced in House
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
Introduced in House · EN · 21 February 2025
Introduced in House
summary · EN · 21 February 2025
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Hudson, Richard [R-NC-8] · R · Sponsor
- Rep. Davis, Donald G. [D-NC-1] · D · Sponsor
- Rep. Murphy, Gregory F. [R-NC-3] · R · Sponsor
- Rep. Peters, Scott H. [D-CA-50] · D · Sponsor
- Rep. Rouzer, David [R-NC-7] · R · Cosponsor
- Rep. Knott, Brad [R-NC-13] · R · Cosponsor
- · hswm00 · Standing
- · hsif00 · Standing
Related records
- related to ← PLASMA Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/119th-congress/house-bill/1476
- Open data entity: https://api.congress.gov/v3/bill/119/hr/1476
- us · 119-hr-1476 · source updated 5 December 2025